Skip to Main Content (Press Enter)

Logo UNILINK
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations

UNI-FIND
Logo UNILINK

|

UNI-FIND

unilink.it
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  1. Outputs

The retinoblastoma-related Rb2/p130 gene is an effector downstream of AP-2 during neural differentiation

Academic Article
Publication Date:
2001
abstract:
Rb2/p130, a member of the Retinoblastoma family of growth and tumour suppressor genes, is extensively implicated in the control of cell cycle and differentiation. The minimal promoter region of Rb2/p130 in T98G human glioblastoma cells was identified and its analysis revealed the presence of a KER1 palindromic sequence able to bind the transcription factor AP-2, a regulatory protein that plays a crucial role in ectodermal differentiation. This KER1 site interacted in vitro with AP-2, and AP-2 overexpression increased Rb2/p130 transcription and translation. We also found that rat PC12 pheochromocytoma cells, when induced to differentiate by NGF, displayed an increase of AP-2 protein levels and of Rb2/p130 transcription and protein levels. AP-2-transfected PC12 cells displayed enhanced transcription and translation of Rb2/p130 and of the cdk inhibitor p21WAFI/CIPI, a gene known to be under the control of AP-2, but unable by itself to elicit PC12 differentiation. Overexpression of either AP-2 or Rb2/p130 elicited per se cell differentiation in the absence of NGF, while coexpression of AP-2B, a negative regulator of AP-2 transcriptional activity, inhibited only AP-2-induced differentiation. Altogether, these results indicate that Rb2/p130 is a critical effector of AP-2 in sustaining ectodermal differentiation.
Iris type:
1.1 Articolo in rivista
Keywords:
AP-2; Differentiation; NGF; PC12; Rb2/p130
List of contributors:
Paggi, Mg; Bonetto, F; Severino, A; Baldi, Alfonso; Battista, T; Bucci, F; Felsani, A; Lombardi, D; Giordano, A.
Authors of the University:
BALDI ALFONSO
Handle:
https://iris.unilink.it/handle/20.500.14085/24321
Published in:
ONCOGENE
Journal
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.7.2.0